International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Effect of SGLT-2 Inhibitors on Zebrafish Model with Diabetic Heart Failure

Author(s) Sukanya y. Waghmare, Anjali Wankhade, J.V. Vyas, V.V. Paithankar
Country India
Abstract Diabetes mellitus (DM) has the rapidly increasing pervasiveness worldwide that causes various cardiovascular complications mainly heart failure (HF). The number of people with DM worldwide is over 425 million and is expected to reach 700 million by 2045. Heart Failure (HF) is the heart’s inability to provide sufficient blood to meet the body’s needs. Heart failure (HF), a major public health problem with considerable morbidity and mortality, is often accompanied by various degrees of progressively pathological enlargement of the left ventricular and abnormal cardiac remodelling by 2030; almost 3% of the population is predicted to have HF. Most anti-diabetic drugs have the effect of increasing the metabolic risk of diabetes in heart failure, since they raise the risk of death and hospitalization for heart failure in patients with and without heart failure. Since lenient glycaemic control with newer therapeutic agents has shown to significantly reduce mortality, morbidity, and risk of developing heart failure in diabetic patients with proven cardiovascular disease, this effect may be related to a direct effect of the glucose-lowering molecules on the cardiovascular system and/or to a negative effect of excessive glucose lowering.
Keywords Diabetes mellitus, Heart failure, zebrafish model, SGLT2 inhibitors
Published In Volume 6, Issue 3, May-June 2024
Published On 2024-06-20
Cite This Effect of SGLT-2 Inhibitors on Zebrafish Model with Diabetic Heart Failure - Sukanya y. Waghmare, Anjali Wankhade, J.V. Vyas, V.V. Paithankar - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.22693
DOI https://doi.org/10.36948/ijfmr.2024.v06i03.22693
Short DOI https://doi.org/gt2b89
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com